Freestone Capital Holdings’s Neurocrine Biosciences NBIX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-27	Closed	-$2.59K	–	846
2020 Q4	$2.59K	Hold	27	–	–	﹤0.01%	1099
2020 Q3	$2.6K	Buy	+27	New	+$2.6K	﹤0.01%	991